Brief: Lipocine Inc - Reported A Net Loss Of $2.6 Million, Or $0.04 Per Diluted Share For Quarter Ended June 30, 2022
Aug 8 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES FINANCIAL RESULTS FOR THE SECOND
QUARTER
ENDED JUNE 30, 2022
* Q2 LOSS PER SHARE $0.04
* REPORTED A NET LOSS OF $2.6 MILLION, OR $0.04 PER DILUTED
SHARE
FOR QUARTER ENDED JUNE 30, 2022
Source text for Eikon: ID:nPn8kSSNMa
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy